Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
Globe Newswire•27/10/2026•08:00 ET
0
Key Highlights
- ➤Legend Biotech will report third quarter 2026 financial results November 10, 2026
- ➤Investor conference call scheduled for 8:00 a.m. ET on November 10
- ➤Management will review quarterly financial performance during the webcast
BRIDGEWATER N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 a.m. ET on Tuesday, November 10, 2026, to review third quarter 2026 financial results.
During the conference call and accompanying webcast, senior management will provide an overview of quarterly financial performance.
Get started
Create a free account to read the full story.